A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer | Zendy

B. H. O'Neil | Zendy; A. J. Scott | Zendy; W. W. Ma | Zendy; S. J. Cohen | Zendy; D. L. Aisner | Zendy; A. R. Menter | Zendy; M. A. Tejani | Zendy; J. K. Cho | Zendy; J. Granfortuna | Zendy; L. Coveler | Zendy; Olugbenga Olowokure | Zendy; J. C. Baranda | Zendy; M. Cusnir | Zendy; P. Phillip | Zendy; J. Boles | Zendy; R. Nazemzadeh | Zendy; M. Rarick | Zendy; D. J. Cohen | Zendy; J. Radford | Zendy; L. Fehrenbacher | Zendy; R. Bajaj | Zendy; V. Bathini | Zendy; P. Fanta | Zendy; J. Berlin | Zendy; Autumn McRee | Zendy; R. Maguire | Zendy; F. Wilhelm | Zendy; M. Maniar | Zendy; A. Jimeno | Zendy; C. L. Gomes | Zendy; Wells A. Messersmith | Zendy

Open Access

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

Author(s) -

B. H. O'Neil,

A. J. Scott,

W. W. Ma,

S. J. Cohen,

D. L. Aisner,

A. R. Menter,

M. A. Tejani,

J. K. Cho,

J. Granfortuna,

L. Coveler,

Olugbenga Olowokure,

J. C. Baranda,

M. Cusnir,

P. Phillip,

J. Boles,

R. Nazemzadeh,

M. Rarick,

D. J. Cohen,

J. Radford,

L. Fehrenbacher,

R. Bajaj,

V. Bathini,

P. Fanta,

J. Berlin,

Autumn McRee,

R. Maguire,

F. Wilhelm,

M. Maniar,

A. Jimeno,

C. L. Gomes,

Wells A. Messersmith

Publication year - 2015

Publication title -

carolina digital repository (university of north carolina at chapel hill)

Language(s) - English

DOI - 10.17615/gbtr-cn80

Subject(s) - gemcitabine , pancreatic cancer , medicine , oncology , phases of clinical research , randomized controlled trial , deoxycytidine , cancer , clinical trial

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research